Z ${site.data.firmName}Est. 2001
Have a case? Call us:
207-775-4255
  • Hundreds of jury trials
  • Multi-millions in verdicts and settlements
  • Major not guilty verdicts
  • High stakes litigation

Injuries Archives

Tom Hallett Wins Maine Supreme Court Appeal In Noyes Street Fire Case

HZW Shareholder and Senior Partner Tom Hallett won an appeal to the Maine Supreme Court yesterday.  Hallett argued on appeal that the Superior Court had improperly ordered the priority of the liens against the Defendant/Landlord in this case.  By winning the appeal, Hallett restored our Client to having first priority in the assets of the Defendant.  

Amgen Pays $71 Million In Multistate Drug-Marketing Settlement

By Beasley Allen

Amgen Inc. has agreed to a $71 million settlement with 48 state attorneys general who accused the drugmaker of marketing its anemia drug Aranesp and plaque psoriasis drug Enbrel, both biologic medications, for uses beyond the scope of U.S. Food and Drug Administration (FDA) approval. The drugmaker, based in California, agreed to a consent judgment last month with New York Attorney General Eric Schneiderman and other Attorneys General after they claimed it marketed Aranesp for cancer-related anemia without FDA approval and promoted Enbrel to treat mild plaque psoriasis - an auto-immune problem that causes the flaking and scaling of skin cells - even though the drug is only approved for more serious forms of the condition.